Objective To observe the expression levels of β2 integrin and Fractalkine in peripheral blood of patients with acute coronary syndrome (ACS) and to explore the possible mechanism. Methods Totally 86 patients with ACS admitted to our hospital were enrolled, including 32 patients with unstable angina (UA) and 54 patients with acute myocardial infarction (AMI). Another 20 patients with normal coronary angiography and 28 patients with stable angina (SAP) were regarded as control. The percentage of β2 integrin LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) positive cells in peripheral blood leukocytes was detected by flow cytometry. The levels of Fractalkine and ICAM-1 in serum were detected by ELISA. The expression levels of FAK and Akt in peripheral blood leukocytes were assessed by Western blotting. Results The percentages of LFA-1, Mac-1 positive cells and the expression of FAK, PKB protein in peripheral blood leukocytes of AMI group and UA group were significantly higher than those of normal group and SAP group (P < 0.05). The levels of Fractalkine and ICAM-1 in patients with coronary heart disease were significantly higher than those with normal coronary angiography (P < 0.05). The levels of Fractalkine and ICAM-1 in the serum of patients with AMI were the highest in the four groups (P < 0.05). Conclusions Increased Fractalkine that released in the peripheral circulation during ACS binds to the receptors on the surface of leukocytes and promotes activation of β2 integrin and adhesion molecules. The FAK-PI3K/PKB signaling pathway was activated and participated in inflammatory responses of ACS.